Related references
Note: Only part of the references are listed.The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
Uwe Platzbecker et al.
LEUKEMIA RESEARCH (2012)
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
Pierre Fenaux et al.
BLOOD (2011)
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
Luca Malcovati et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes. A systematic review
Deborah J. Pinchon et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes
Giovanni Caocci et al.
EXPERT REVIEW OF HEMATOLOGY (2009)
International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes
Jelena M. Kao et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
Alan List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Bruce D. Cheson et al.
BLOOD (2006)
The myelodysplastic syndromes: Diagnosis and treatment
DP Steensma et al.
MAYO CLINIC PROCEEDINGS (2006)
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
L Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hemoglobin level threshold for cardiac remodeling and quality of life in myelodysplastic syndrome
EN Oliva et al.
LEUKEMIA RESEARCH (2005)
Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes
AJG Jansen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor:: significant effects on quality of life
E Hellström-Lindberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
More concern about transfusion requirement when evaluating quality of life in anemic patients
EN Oliva et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
JL Gabrilove et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
